Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 2 selected

Type

Guidance programme

Showing 1951 to 2000 of 2056

TitleReference numberPublishedLast updated
TuberculosisNG33
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancerDG58
Tunnelled peritoneal drainage catheter insertion for refractory ascites in cirrhosisIPG746
Twin and triplet pregnancyNG137
Type 1 diabetes in adultsQS208
Type 1 diabetes in adults: diagnosis and managementNG17
Type 2 diabetes in adultsQS209
Type 2 diabetes in adults: managementNG28
Type 2 diabetes prevention: population and community-level interventionsPH35
Type 2 diabetes: prevention in people at high riskPH38
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal)TA790
Ulcerative colitis: managementNG130
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosisIPG523
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolismIPG524
Ultrasound-guided catheterisation of the epidural spaceIPG249
Ultrasound-guided foam sclerotherapy for varicose veinsIPG440
Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroidsIPG657
Ultrasound-guided percutaneous radiofrequency ablation for benign thyroid nodulesIPG562
Ultrasound-guided regional nerve blockIPG285
Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's diseaseIPG606
Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremorIPG617
Unintentional injuries in the home: interventions for under 15sPH30
Unintentional injuries on the road: interventions for under 15sPH31
Unintentional injuries: prevention strategies for under 15sPH29
Upadacitinib for previously treated moderately to severely active Crohn's diseaseTA905
Upadacitinib for treating active ankylosing spondylitisTA829
Upadacitinib for treating active non-radiographic axial spondyloarthritisTA861
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Upadacitinib for treating moderate rheumatoid arthritisTA744
Upadacitinib for treating moderately to severely active ulcerative colitisTA856
Upadacitinib for treating severe rheumatoid arthritisTA665
UrgoStart for treating diabetic foot ulcers and leg ulcersMTG42
Urinary incontinence and pelvic organ prolapse in women: managementNG123
Urinary incontinence in neurological disease: assessment and managementCG148
Urinary incontinence in womenQS77
Urinary tract infection (catheter-associated): antimicrobial prescribingNG113
Urinary tract infection (lower): antimicrobial prescribingNG109
Urinary tract infection (recurrent): antimicrobial prescribingNG112
Urinary tract infection in children and young peopleQS36
Urinary tract infection in under 16s: diagnosis and managementNG224
Urinary tract infections in adultsQS90
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasiaMTG58
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Ustekinumab for moderately to severely active Crohn's disease after previous treatmentTA456
Ustekinumab for the treatment of adults with moderate to severe psoriasisTA180
Ustekinumab for treating active psoriatic arthritisTA340
Ustekinumab for treating moderately to severely active ulcerative colitisTA633
Uterine artery embolisation for fibroidsIPG367
Uterine artery embolisation for treating adenomyosisIPG473

Results per page

  1. 10
  2. 25
  3. 50
  4. All